… present research, we hypothesized that, at very early stages in the preclinical Alzheimer’s
continuum, there may be two distinct … CU individuals with a high proportion of AD patients’ …

… patients based on distinct cut-off values for core biomarkers … from healthy volunteers were
acquired in the context of spinal … present but, at least in our sample, not statistically significant. …

… of cerebrospinal fluid (CSF) biomarkers complementing … associations with biomarkers in the
NTK that are not specific to … SHARP participants (n = 66) received a different cognitive battery …

… individuals (n = 99, 64–93 years) with different profiles of the … clustering individuals from the
entire cognitive continuum … the association between neurodegeneration and memory decline …

… ) between patients with normal AD biomarkers and patients with … a combination of different
essential CSF AD biomarkers, CSF … those with AD from cognitively normal individuals and to …

… +) would define the AD continuum, and the association of A + … analysis, in a cohort of patients
attending a memory clinic in a … this study are outpatients at our memory clinic, most of whom …

… predicting cerebrospinal fluid (CSF) AD biomarkers positivity … tangles (NFTs) deposition in
AD continuum 26 . Conversely, the … a strong association of memory impairment with CSF AD …

… thus takes into account the continuum of Alzheimer’s disease … When comparing individual
CSF biomarkers with separate … association between Alzheimer’s disease CSF biomarkers …

… that encompasses different clinical stages. … in memory and executive domains in MCI subjects
with AD pathology (… low performance in different memory tasks in MCI and AD patients [17…

… were significantly different in Alzheimer’s disease patients; the … a specialized memory clinic,
where the patients were followed … on Aging and the Alzheimer’s Association issued research …